Lifeward (NASDAQ:LFWD – Get Free Report) is expected to be announcing its Q4 2025 results before the market opens on Friday, March 6th. Analysts expect Lifeward to post earnings of ($0.07) per share and revenue of $7.8680 million for the quarter. Parties can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Friday, March 6, 2026 at 9:30 AM ET.
Lifeward Trading Up 7.5%
LFWD opened at $6.47 on Friday. The company’s 50 day moving average is $7.18 and its 200 day moving average is $7.51. The company has a market cap of $9.83 million, a price-to-earnings ratio of -0.18 and a beta of 0.16. Lifeward has a 12-month low of $4.14 and a 12-month high of $35.40.
Analyst Ratings Changes
Several research analysts have recently weighed in on LFWD shares. Weiss Ratings reiterated a “sell (e+)” rating on shares of Lifeward in a research note on Thursday, January 22nd. HC Wainwright decreased their target price on Lifeward from $156.00 to $54.00 and set a “buy” rating on the stock in a report on Tuesday, November 18th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $51.00.
Institutional Inflows and Outflows
Large investors have recently modified their holdings of the company. Citadel Advisors LLC increased its holdings in shares of Lifeward by 1,271.8% in the third quarter. Citadel Advisors LLC now owns 214,006 shares of the company’s stock worth $152,000 after purchasing an additional 198,406 shares during the last quarter. Jane Street Group LLC grew its holdings in Lifeward by 77.3% during the 4th quarter. Jane Street Group LLC now owns 68,631 shares of the company’s stock valued at $40,000 after buying an additional 29,927 shares in the last quarter. Virtu Financial LLC increased its stake in Lifeward by 158.0% in the 4th quarter. Virtu Financial LLC now owns 60,474 shares of the company’s stock worth $35,000 after acquiring an additional 37,037 shares during the last quarter. Finally, HRT Financial LP raised its holdings in shares of Lifeward by 149.7% during the 4th quarter. HRT Financial LP now owns 49,081 shares of the company’s stock worth $28,000 after acquiring an additional 29,423 shares in the last quarter. Hedge funds and other institutional investors own 26.76% of the company’s stock.
About Lifeward
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.
Featured Stories
- Five stocks we like better than Lifeward
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Lifeward Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lifeward and related companies with MarketBeat.com's FREE daily email newsletter.
